Research Article

Clinical Implication and the Hereditary Factors of NM23 in Hepatocellular Carcinoma Based on Bioinformatics Analysis and Genome–Wide Association Study

Table 2

Association between haplotypes of PSORS1C1 and STARD3 and NM23 expression.

HaplotypesNM23Ad ORP–valueAd P–valueAd P–value
1+2+3+ (95% CI) (95% CI)(95% CI)

PSORS1C1
 TGCACA402736163Ref.Ref.Ref.
 CAGGTG3717119200.44
(0.3 0–0.65)
2.70 × 10-50.71
(0.42–1.22)
0.2190.87
(0.46–1.63)
0.653
 CAGACA664950.56
(0.32–0.99)
0.0480.99
(0.65–1.51)
0.9671.66
(0.95–2.90)
0.073
 Others336360.60
(0.3 0–1.18)
0.1350.97
(0.74–1.27)
0.8052.04
(0.99–4.20)
0.054
 All others4627131310.48
(0.35–0.68)
2.05 × 10-50.93
(0.73–1.18)
0.5610.74
(0.50–1.10)
0.136
STARD3
 GG463295869Ref.Ref.
 Others4020934250.65
(0.47–0.91)
0.0120.97
(0.76–1.24)
0.8141.18
(0.74–1.88)
0.498

Note. OR, HR and P–value are adjusted for age, gender, race, smoking status, drinking status, BMI, BCLC stage, Child–Pugh stage, preoperative serum AFP level, TACE status before hepatectomy, pathological grade, cirrhosis, intrahepatic metastasis, PVTT, regional invasion, radical resection, and use of antiviral therapies. Others include CGCACA and CGGGCA. The group of all others is merged CAGGTG, CAGACA, CGCACA, and CGGGCA. Others include CA, GA, CG, and the total number of patients harbour GA and CG is 6.
Abbreviations. OR: odds ratio; HR: hazard ratio; 95% CI: 95% confidence intervals; Ad: adjusted.